LGG/BB12-pastille Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01577485

Enrollment

Registered

2012-04-13

Start date

2012-08-31

Completion date

2012-11-30

Last updated

2013-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Probiotics

Brief summary

We want to study the effect of short-term consumption of probiotics (a mixture of L. rhamnosus GG and B. lactis BB-12)on the composition of the oral flora.

Interventions

DIETARY_SUPPLEMENTProbiotics in an pastille

Test group

DIETARY_SUPPLEMENTControl pastille

Control group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* Subjects healthy, 20-30 yrs of age

Exclusion criteria

* Subjects not healthy, too old/young

Design outcomes

Primary

Measure	Time frame
Counts of mutans streptococci	4 weeks

Secondary

Measure	Time frame
Amount of plaque	4 weeks

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026